risks of taking glp 1 for weight loss Key Takeaways Patients GLP-1 receptor agonists had a 41% lower risk obesity-associated cancers compared with patients prescribed diet or exercise. Patients taking tirzepatide had substantially greater cancer Long-term Success of GLP-1s Hinges
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5


























